Top Pharmaceuticals companies in Switzerland by Operating Income Margin
Switzerland
# |
Name |
Operating Income Margin |
Reported Date | Stock Price |
Change |
Price (30 days) | Country |
|---|---|---|---|---|---|---|---|
| 1 |
66.57%
|
Dec. 31, 2023 | USD 14.50 | 8.00% |
|
Switzerland |
|
| 2 |
27.53%
|
March 31, 2024 | USD 229.49 | 0.50% |
|
Switzerland |
|
| 3 |
25.47%
|
Dec. 31, 2023 | USD 310.22 | 0.71% |
|
Switzerland |
|
| 4 |
22.41%
|
Dec. 31, 2023 | USD 61.01 | 0.32% |
|
Switzerland |
|
| 5 |
20.94%
|
Dec. 31, 2023 | USD 98.71 | -0.26% |
|
Switzerland |
|
| 6 |
17.04%
|
Dec. 31, 2023 | USD 129.81 | 2.09% |
|
Switzerland |
|
| 7 |
15.72%
|
March 31, 2024 | USD 355.46 | -1.48% |
|
Switzerland |
|
| 8 |
14.57%
|
Dec. 31, 2023 | USD 119.40 | 0.87% |
|
Switzerland |
|
| 9 |
13.53%
|
Dec. 31, 2023 | USD 1.04 K | -2.38% |
|
Switzerland |
|
| 10 |
13.27%
|
Dec. 31, 2023 | USD 85.22 | -0.53% |
|
Switzerland |
|
| 11 |
13.10%
|
Dec. 31, 2023 | USD 588.68 | -0.80% |
|
Switzerland |
|
| 12 |
12.66%
|
Dec. 31, 2023 | USD 244.50 | 0.95% |
|
Switzerland |
|
| 13 |
12.18%
|
Dec. 31, 2023 | USD 44.53 | -0.85% |
|
Switzerland |
|
| 14 |
11.80%
|
Dec. 31, 2023 | USD 81.72 | -0.97% |
|
Switzerland |
|
| 15 |
11.36%
|
Dec. 31, 2023 | USD 165.41 | 0.50% |
|
Switzerland |
|
| 16 |
10.99%
|
Dec. 31, 2023 | USD 82.92 | 0.05% |
|
Switzerland |
|
| 17 |
10.46%
|
Dec. 31, 2023 | USD 140.65 | 0.97% |
|
Switzerland |
|
| 18 |
8.08%
|
Dec. 31, 2023 | USD 56.52 | -0.28% |
|
Switzerland |
|
| 19 |
5.11%
|
Dec. 31, 2023 | USD 84.29 | 1.29% |
|
Switzerland |
|
| 20 |
4.29%
|
Dec. 31, 2023 | USD 73.39 | 4.71% |
|
Switzerland |
|
| 21 |
3.76%
|
Dec. 31, 2023 | USD 42.16 | 0.08% |
|
Switzerland |
|
| 22 |
3.29%
|
Dec. 31, 2023 | USD 11.09 | -3.14% |
|
Switzerland |
|
| 23 |
2.78%
|
Dec. 31, 2023 | USD 1.16 K | 0.97% |
|
Switzerland |
|
| 24 |
2.76%
|
Dec. 31, 2023 | USD 73.83 | -0.24% |
|
Switzerland |
|
| 25 |
-4.68%
|
Dec. 31, 2023 | USD 97.52 | 0.29% |
|
Switzerland |
|
| 26 |
-7.82%
|
Dec. 31, 2023 | USD 19.40 | 2.88% |
|
Switzerland |
|
| 27 |
-11.38%
|
Dec. 31, 2023 | USD 27.99 | -3.47% |
|
Switzerland |
|
| 28 |
-39.30%
|
Dec. 31, 2023 | USD 24.15 | -4.07% |
|
Switzerland |
|
| 29 |
-59.95%
|
Dec. 31, 2023 | USD 38.36 | -1.26% |
|
Switzerland |
|
| 30 |
-238.63%
|
Dec. 31, 2023 | USD 1.71 | -0.58% |
|
Switzerland |
|
| 31 |
-362.30%
|
Dec. 31, 2023 | USD 2.61 | NA |
|
Switzerland |
|
| 32 |
-637.42%
|
Dec. 31, 2023 | USD 7.39 | -3.40% |
|
Switzerland |
|
| 33 |
-868.26%
|
Dec. 31, 2023 | USD 5.48 | 3.60% |
|
Switzerland |
|
| 34 |
-9,140.88%
|
Dec. 31, 2023 | USD 22.44 | 0.27% |
|
Switzerland |
Frequently Asked Questions
-
Which Pharmaceuticals company in Switzerland has the highest Operating Income Margin ?
The Pharmaceuticals company in Switzerland with the highest Operating Income Margin is Santhera Pharmaceuticals Holding AG (Swiss Stock Exchange: SANN.SW) at 66.57%.
-
Which Pharmaceuticals company in Switzerland has the lowest Operating Income Margin ?
The Pharmaceuticals company in Switzerland with the lowest Operating Income Margin is Oculis Holding AG (NasdaqGM: OCS) at -9,140.88%.
-
What are the top 10 Pharmaceuticals companies in Switzerland by Operating Income Margin ?
The top 10 Pharmaceuticals companies in Switzerland by Operating Income Margin are Santhera Pharmaceuticals Holding AG, Dottikon Es Holding AG, Roche Holding AG, Bachem Holding AG, Novartis AG, Straumann Holding AG, Ypsomed Holding AG, Medacta Group SA, Siegfried Holding AG and CPH Chemie + Papier Holding AG.
-
What are the bottom 10 Pharmaceuticals companies in Switzerland by Operating Income Margin ?
The bottom 10 Pharmaceuticals companies in Switzerland by Operating Income Margin are Oculis Holding AG, Molecular Partners AG, Addex Therapeutics Ltd, AC Immune SA, ADC Therapeutics SA, CRISPR Therapeutics AG, Kuros Biosciences AG, PolyPeptide Group AG, DocMorris AG and DSM-Firmenich AG.